Nanovaccine for Brucellosis Using Green Technology

Vandana Patravale of the Institute of Chemical Technology in India will develop a sub-unit nanovaccine using green technology against brucellosis, a zoonotic disease which is endemic in sub-Saharan West Africa. The vaccine will be developed for non-invasive intranasal administration and the investigators will study vaccine delivery and its ability to induce a strong protective immune response against Brucella in mice, with a view to future clinical testing in humans.